Study type

Study topic

Human medicinal product
DiseaseĀ /health condition

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Drug utilisation

Data collection methods

Combined primary and secondary data collection
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(R03) DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES

Medical condition to be studied

Asthma
Population studied

Short description of the study population

Persistant asthma patients in France and in UK included between May 2013 and February 2015.

Age groups

Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)

Special population of interest

Other

Special population of interest, other

Asthma patients

Estimated number of subjects

3000
Study design details

Main study objective

The overall objective of the project is to compare the rate of severe asthma exacerbation in children and adults treated by LABAs without ICs and with concomitant ICs with the rate amongst those treated by ICs without LABAs under the conditions of routine clinical care, after adjusting for baseline differences in severity.

Outcomes

Severe Asthma exacerbation. In the Astro-lab study, the definition of severe asthma exacerbation will be the combination of patient-reported courses of oral corticosteroids for asthma, asthma-related urgent medical visits, asthma-related hospital contacts or death. Adherence, Asthma control and quality of life.

Data analysis plan

Descriptive statistics will be provided for each exposure group. In addition different types of analysis are planned : - analysis based on the 4 initial exposure groups "intention to treat"- Cohort analysis with time-dependent variables analysis- Case -crossover study approach (if applicable)- Nested case control study (if applicable)
Documents
Study results
English (118.37 KB - PDF)View document
Study publications